Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Groups Sue To Stop ‘Ticking Time Bomb’ Of SUNSET Reg Review Proposal

Executive Summary

The lawsuit argues that the regulatory review proposal was “arbitrary and capricious” and should not be allowed to go into effect.

You may also be interested in...



Pending Litigation Delays Implementation Of SUNSET Regulation Review Policy To 2022

HHS says trying to implement the rule while it is still being litigated could create confusion for the public, among other problems.

Sunset for SUNSET? Implementation Of Reg Review Policy Delayed To 2022 Pending Legal Battle

The US Department of Health and Human Services says trying to implement the rule while it is still being litigated could create confusion for the public, among other problems.

ACA Champion Becerra Confirmed As HHS Chief

The former Congressman and California attorney general was confirmed with only one GOP vote. He’ll be integral to managing the pandemic as well as implementing the ACA and reimbursement policy.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143659

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel